Microbix Biosystems Inc.
MBXBF
$0.16
$0.013.45%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.26M | 15.15M | 16.34M | 16.81M | 18.67M |
| Total Other Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Revenue | 13.26M | 15.15M | 16.34M | 16.81M | 18.67M |
| Cost of Revenue | 6.24M | 6.71M | 6.91M | 7.39M | 7.35M |
| Gross Profit | 7.01M | 8.44M | 9.43M | 9.42M | 11.32M |
| SG&A Expenses | 6.51M | 6.41M | 6.36M | 6.12M | 6.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.42M | 14.76M | 14.89M | 15.14M | 15.81M |
| Operating Income | -1.17M | 393.30K | 1.45M | 1.66M | 2.86M |
| Income Before Tax | -1.68M | -127.50K | 1.24M | 1.51M | 2.70M |
| Income Tax Expenses | -40.50K | 110.40K | 110.40K | 110.40K | 110.40K |
| Earnings from Continuing Operations | -1.64 | -0.24 | 1.13 | 1.40 | 2.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.64M | -237.90K | 1.13M | 1.40M | 2.59M |
| EBIT | -1.17M | 393.30K | 1.45M | 1.66M | 2.86M |
| EBITDA | -21.00K | 1.33M | 2.37M | 2.59M | 3.81M |
| EPS Basic | -0.01 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -0.01 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 551.56M | 555.65M | 551.91M | 549.44M | 550.93M |
| Average Diluted Shares Outstanding | 552.99M | 557.83M | 554.85M | 553.35M | 554.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |